Physician profile
Anthony D Colonna
NPI 1811337603
$37,616.35
in general payments reported to CMS, 2019-2025
31 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,377 · 2020: $1,820 · 2021: $3,986 · 2022: $591 · 2023: $4,438 · 2024: $12K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,250 · Food and Beverage: $5,973 · Travel and Lodging: $4,978 · Education: $16.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,625.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,250.00 |
| Food and Beverage | $5,973.01 |
| Travel and Lodging | $4,977.73 |
| Education | $16.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $22,758.10 | 2019-2025 | Versajet, Grafix Pl, Stravix Pl |
| Arthrex, INC. | $8,364.26 | 2019-2025 | |
| Mid-Atlantic Surgical Systems, LLC | $1,366.35 | 2019-2025 | |
| Orthofix Medical, INC. | $1,356.39 | 2023 | Truelok, Truelok System |
| Organogenesis INC. | $931.37 | 2019-2025 | Puraply, Puraply Wound Matrix, Apligraf |
| Kerecis Limited | $489.79 | 2019-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Osiris Therapeutics INC. | $478.58 | 2019 | |
| Integra Lifesciences Corporation | $378.66 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Misonix INC | $157.09 | 2021 | |
| Treace Medical Concepts, INC. | $146.69 | 2024-2025 | |
| Depuy Synthes Sales INC. | $140.61 | 2025 | Na |
| Stryker Corporation | $137.10 | 2020-2025 | Citrefix, 7 X 23mm Citrelock Implant |
| Bone Support INC. | $111.62 | 2024 | Ceramentbone Void Filler, Cerament G |
| Urgo Medical North America, LLC | $110.67 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Acell, INC. | $98.34 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flower Orthopedics Coporation | $93.06 | 2022-2023 | |
| Medtronic, INC. | $80.95 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Musculoskeletal Transplant Foundation INC. | $63.00 | 2020 | |
| Merck Sharp & Dohme LLC | $42.67 | 2024 | Verquvo, Dificid |
| Innovation Technologies INC | $38.35 | 2023-2025 | Irrisept |
| Davol INC. | $36.36 | 2022-2023 | |
| Abbott Laboratories | $35.45 | 2025 | Proclaim |
| Lifenet Health | $33.10 | 2024-2025 | Theragenesis Wound Matrix |
| Bioventus LLC | $29.87 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Mimedx Group, INC. | $26.88 | 2025 | |
| Paragon 28, INC. | $22.55 | 2024 | Portfolio |
| Solventum Corporation | $22.26 | 2025 | Activ.A.C. |
| Novo Nordisk INC | $18.46 | 2025 | Wegovy |
| Lexicon Pharmaceuticals, INC. | $16.72 | 2024 | |
| Hartmann USA, INC. | $16.08 | 2025 | Zetuvit Plus 10x10 P10 |
| Linvatec Corporation | $14.97 | 2024 | Fracture and Correction Colag 2, In2bones USA, Quantum |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Colonna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.